-
Healthcare Costs of Mammography Screening and Breast Cancer Treatment: A Registry-Based Study From Norway
Sep 9, 2025, 16:22 PM -
Economic Evaluation of the Breast Thermal Activity Indicator Plus Clinical Breast Examination
Sep 9, 2025, 16:22 PM -
Pharmacists’ Engagement With Pharmaceutical Care in Pakistan: Insights From a Cross-Sectional Survey on Knowledge, Attitudes, Practices, and Barriers
Sep 9, 2025, 16:22 PM -
A Health Economic Evaluation of Daylight: A Digital Treatment for Anxiety in NHS South Yorkshire
Sep 9, 2025, 16:22 PM -
European and US Drug Shortages: A Critical Analysis of Key Trends and Causes
Sep 9, 2025, 16:22 PM -
Assessing Conditional Cash Transfers for Tuberculosis Patients in India: An Extended Cost-Effectiveness Analysis
Sep 9, 2025, 16:22 PM -
Beyond RCTs: The Role of Patient Perspectives and Nontraditional Evidence in HTA Decisions for Breast Cancer (BC) and Non-Small Cell Lung Cancer (NSCLC)
Sep 9, 2025, 16:22 PM -
What Is the Impact of Patient Voice on NICE Recommendations for Drugs Assessed in 2024?
Sep 9, 2025, 16:22 PM -
Years of Life Lost and Productivity Costs Due to Premature Cancer-Related Mortality in Ukraine and in Kiev City, Lviv, and Cherkasy Regions
Sep 9, 2025, 16:22 PM -
The Challenges of Evaluating Individualized Therapies in Health Technology Assessment: A Thematic Review
Sep 9, 2025, 16:22 PM -
Cost-Utility Analysis of the BCIS Conveyance Algorithm for Out-of-Hospital Cardiac Arrest Patients
Sep 9, 2025, 16:22 PM -
The Economic Burden of Diabetes-Related Blindness and Vision Impairment in Saudi Arabia
Sep 9, 2025, 16:22 PM -
Mapping Disease-Specific Patient-Reported Outcome Measures (PROMs) to EQ-5D Utility Scores: A Systematic Review
Sep 9, 2025, 16:22 PM -
Effectiveness of Inclisiran and Evolocumab in LDL-C Goal Attainment: A Hybrid Decision Tree-Markov Model Analysis
Sep 9, 2025, 16:22 PM -
Comparing Countries’ Time to Treatment Initiation: A Study of Metastatic Breast Cancer in Austria and the United States
Sep 9, 2025, 16:22 PM -
Economic Burden of Pneumococcal Disease—Impact of Age and Underlying Medical Conditions
Sep 9, 2025, 16:22 PM -
From Pain to Patient Preferences Patient Engagement in Early HTA for Repurposing Losartan in Osteogenesis Imperfecta
Sep 9, 2025, 16:22 PM -
HTA Conflicts in Europe: Agreeing to Disagree?
Sep 9, 2025, 16:22 PM -
Baseline Risk Heterogeneity in Cost-Effectiveness Analysis of the Diabetes Prevention Program
Sep 9, 2025, 16:22 PM -
Evolving Trends in Patient Demographics and Diagnosis in Gastric Cancer: A Real-World Analysis From US Community Oncology Practices From 2014 to 2024
Sep 9, 2025, 16:22 PM
